How often should I retest my blood biomarkers?

Short answer: it depends — on which biomarkers, whether you have chronic disease or take medications, and whether results are normal or changing. Below are practical, evidence-informed guidelines plus service recommendations.

General rules of thumb

• Healthy adult, no meds, stable results: once a year for a basic panel (CBC, CMP/basic metabolic panel, lipid panel).
• Starting or changing a medication that affects labs (statin, thyroid hormone, anticoagulant, certain psychiatric or immunosuppressant drugs): check sooner (weeks–months) and then more frequently until stable.
• Chronic disease (diabetes, hypothyroidism, kidney disease, liver disease, autoimmune disease): commonly checked every 3–12 months depending on stability and treatment.
• Abnormal results: recheck sooner to confirm trend or response to treatment (often 4–12 weeks).
• Acute illness or new symptoms: test as clinically indicated.

Common biomarkers and typical retest intervals

• Lipid panel (cholesterol, LDL, HDL, triglycerides): baseline, 4–12 weeks after starting or changing statins, then every 3–12 months until stable, then annually.
• HbA1c (diabetes control): every 3 months when therapy is changing or goals not met; every 3–6 months or twice yearly once stable and at goal.
• Fasting glucose: annually if low risk; more often if prediabetes or diabetes.
• Basic metabolic panel / electrolytes / kidney function (creatinine, eGFR): annually if healthy; more often if on ACE inhibitors, ARBs, diuretics, or with CKD.
• CBC (anemia, infection, blood counts): annually if healthy; sooner if unexplained symptoms or on bone-marrow–affecting drugs.
• TSH (thyroid): 6–8 weeks after changing levothyroxine dose, then every 6–12 months if stable.
• Vitamin D / B12 / ferritin (iron): recheck about 8–12 weeks after starting replacement therapy, then 6–12 months depending on stability.
• hs‑CRP or other inflammatory markers: as needed to track disease activity or cardiovascular risk changes.
• PSA (prostate cancer screening): individualized by age/risk — discuss with your clinician (common intervals 1–4 years).
• INR (warfarin therapy): frequent checks at start, then interval depends on stability; consider home INR monitoring (CoaguChek) if long-term.
• Liver enzymes and CK (when on statins or other hepatotoxic/myotoxic drugs): get baseline; recheck if symptoms or per clinician plan (often after med change or if symptomatic).

Where to get tests

• Quest Diagnostics or LabCorp — large national lab networks, widely accepted by insurance, many draw sites.
• Everlywell or LetsGetChecked — at‑home sample collection kits for many common tests; convenient but check which tests your insurer will cover and confirm clinical follow-up.
• Dexcom or FreeStyle Libre — continuous glucose monitoring devices if you need frequent glucose data (diabetes or detailed metabolic monitoring).
• CoaguChek — validated home INR meters for people on warfarin wanting home monitoring.
• Work with your primary care provider or specialist to order and interpret tests; they’ll coordinate timing and follow-up.

Final tips

• Use trends, not single numbers. Repeat testing frequency should be driven by how results change and whether treatment is being started or adjusted.
• Ask your clinician for a clear follow-up schedule when a new test is ordered or a new medication started.
• If you want, tell me your age, medical conditions, and any medications and I can suggest a more specific retesting schedule.